For the year ending 2025-12-31, BCAB made $2,000K in revenue. -$59,607K in net income. Net profit margin of -2980.35%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Collaboration and other revenue | 2,000 | 11,000 | ||
| Research and development expense | 43,573 | 63,095 | ||
| General and administrative expense | 17,732 | 21,848 | ||
| Total operating expenses | 61,305 | 84,943 | ||
| Loss from operations | -59,305 | -73,943 | ||
| Interest income | 843 | 3,369 | ||
| Gain on warrant liability | 295 | 807 | ||
| Loss on ppas liability | -406 | - | ||
| Other expense | -1,034 | -9 | ||
| Total other income (expense) | -302 | 4,167 | ||
| Consolidated net loss and comprehensive loss | -59,607 | -69,776 | ||
| Basic EPS | -1.01 | -1.44 | ||
| Diluted EPS | -1.01 | -1.44 | ||
| Basic Average Shares | 58,827,934 | 48,573,364 | ||
| Diluted Average Shares | 58,827,934 | 48,573,364 | ||
BioAtla, Inc. (BCAB)
BioAtla, Inc. (BCAB)